… for targeted transgene integration in primary T cells, 31 and … There had been concerns about
triggering natural killer (NK)-… CAR T cells, 107 but the majority of iPSC-derived CAR T cells …

… leukemia and lymphoma samples as targets in vitro and in vivo … CAR-engineered natural
killer (NK) cells hold the potential to … NK-92 cell lines49,50 and of iPSC-derived NK-cells,51 but …

… T-/CAR natural killer (NK)-cell … of iPSC-derived modified NK cell therapy products displaying
optimized potential for expansion and preservation after transplant, and targeted tumor cell …

… Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor
immunity… Human iPSC-derived natural killer cells engineered with chimeric antigen receptors …

… In vitro studies have shown that CAR-NK cells targeting EGFR effectively eradicate breast
cancer cells [141]. Tissue factor-focused natural killer cells have demonstrated notable …

… therapeutic targets, it is essential to elucidate the cellular … iPSC-derived cells were embedded
before cell transplantation. It has been demonstrated, repeatedly, that iPSC-derived cells …

… iPSC-Derived natural killer cell therapies—expansion and targeting. Front Immunol. 13:…
Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti…

… cells to target malignant T cells in vivo, we generated a patient-derived xenograft (PDX) model
in NSG mice (Fig. 2a) populated with total CD4 T cells … of iPSC-derived NK cell production …

… iPSC-derived small extracellular vesicles (iPSCs-sEVs) can carry genetic and proteinaceous
substances and mediate the interaction between iPSCs and target cells. In recent years, …